Event Content & Highlights

Keep Reading

Events

Keep Reading

Anti-Competitive Pricing Practices

There is no excerpt because this is a protected post.

Keep Reading

Home – Equitable Health Care 2

Keep Reading

Rebuttal of USC Schaeffer’s “The Association Between Drug Rebates and List Prices”

A recent white paper (“The Association Between Drug Rebates and List Prices”) narrowly suggests an association between list prices for brand drugs and the rebate practices of pharmacy benefit managers (PBMs) and insurers, despite an underlying methodology that is notably broader and does not isolate to the role of PBMs and insurers.[1] Click here to download...

Keep Reading

Drug Manufacturer Strategies for Keeping Drug Costs High

There is no excerpt because this is a protected post.

Keep Reading

Home Aug 2021

Keep Reading

Transparency Helps Reduce Prescription Drug Costs

There is no excerpt because this is a protected post.

Keep Reading

PCMA Rx Research Corner

Keep Reading

Member Area New


Please visit the Member Login page to view Members Only content.

 

Keep Reading